Orange Grove Bio Provides Corporate Update Highlighting Key Leadership Appointments and Establishment of New Academic Collaboration
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Draupnir Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
This Special Communication describes the development of the STROBE-MR Statement and includes the checklist of recommended items for inclusion in reports of mend
Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer as 1 - Draupnir Bio ("Draupnir"), a biotechnology company developing small molecule modulators of PCSK9 to transform the treatment of heart disease, today announces the appointment of Anna Quattropani, PhD, as Chief Discovery Officer (CDO), effective immediately. Anna brings more than 20 years of experience in drug discovery and development to the role, having established a successful track record in the design of clinical candidates and their development from discovery to the clinic...